August 1, 2018 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/ grants-contracts/funding-news- notices
Feature Articles
Spotlight on the Chemical Countermeasures Research Program Network
The Chemical Countermeasures Research Program focuses exclusively on enhancing the nation's medical response capabilities to protect the civilian population during public health emergencies involving the release of chemical threat agents.
Opportunities and Resources
Prevent Tuberculosis Transmission in HIV-Endemic and Other High-Transmission Settings
Through this funding opportunity, we will support research to characterize tuberculosis transmission events within the Transmitter-Recipient Cluster Chains in high-burden settings, including elucidating the impact of HIV co-infection on transmission rates.
ImmPort(ant) News: Last Chance To Apply for Informatics FOA
We remind you of an opportunity to develop new or improved informatics tools and methods to improve and facilitate reusing shared data in NIAID's data repository ImmPort.
Antibacterial Resistance: Funding To Support a Leadership Group
NIAID looks to fund a leadership group to conduct clinical research studies and clinical trials that will impact understanding, preventing, diagnosing, and treating antibacterial resistance infections.
Commercialization Accelerator Program Returns To Aid Small Business Phase II Awardees
Small businesses: don't miss an opportunity to receive individualized assistance to transition developed products into the marketplace.
In The News
NIAID Payline Updates for Fiscal Year 2018
NIAID adjusted fiscal year paylines for training, fellowship, and small business grants.
eRA Commons Introduces Two Upgrades for Progress Reports
Review two changes in eRA Commons that will make completing your next Research Performance Progress Report even easier.
Find Resources on Rigor and Reproducibility
NIH’s Rigor and Reproducibility page is still the best place to start when completing the Research Plan of your next application. Pay close attention to the listed “Examples of Rigor in Applications” within the Resources section.
Advice Corner
Small Business Applicants: Quickly Find the Right Opportunity for You
NIH posted a Small Business Clinical Trials Funding Opportunity Decision Tree, which, based on your answers, will direct you to the funding opportunity announcement that best matches your intended research.
Reader Questions
- "Do subawardees need to submit a progress report?"
- “I've never been awarded an NIH research grant; however, I was assigned to lead a research project as the principal investigator during the noncompeting phase of an R01 grant. Can I still be considered a new investigator?”
New Funding Opportunities
- PAR-18-879, Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
- RFA-AI-18-029, HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)
- PA-18-872, Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
- PA-18-873, Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
- PAR-18-860, Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
- PA-18-858, Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
- PA-18-859, Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario